Delivery Order SPE2DB25D3404-SPE2DB25FUMVP

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Lidocaine 5% patches, a medical product used for pain management. The contract has a ceiling value of $1,078.82 and runs through April 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Lidocaine 5% patches, a medical product used for pain management. The contract has a ceiling value of $1,414.08 and an ultimate completion date of February 19, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and the contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a medical product used for pain management. The contract has a ceiling value of $8,568.59 and a period of performance through April 4, 2025. The contract is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product used for pain management. The contract has a ceiling value of $1,181.76 and a period of performance through January 28, 2025. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lidocaine 5% Patches, a medical product used for pain management. The contract has a ceiling value of $35,996.76 and an ultimate completion date of April 27, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a pain management product, and has a total ceiling value of $5,548.76. The contract is a firm fixed-price delivery order, with a period of performance through March 4, 2024. This award is part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $18,432.57 and runs through February 26, 2024. It is a firm fixed-price contract and was not set aside for any specific business type. The contract is issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Lidocaine 5% patches. The contract has a ceiling value of $5,261.12 and a completion date of September 20, 2024. The contract is a firm-fixed-price delivery order, which does not utilize a set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract (IDC) vehicle between AmerisourceBergen and...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lidocaine 5% Patches, a medical product used for pain management. The contract has a ceiling value of $1,742.56 and an ultimate completion date of June 14, 2024. This contract is not designated as a set-aside and is an open competition award. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lidocaine 5% Patches, a pharmaceutical product used for pain management. The contract has a ceiling value of $6,482.86 and a period of performance through March 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMVP
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lidocaine 5% Patches, a medical product used for pain management. The contract has a ceiling value of $12,971.24 and a completion date of April 9, 2025. The contract type is Firm Fixed Price. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/8/25, 2:22 PM